As new types of biologic products enter the market,
the need for innovative
processes continues to grow.
This requires improvements
in post-approval
change management.
ICH Q12: Technical and
Regulatory Considerations
for Pharmaceutical Product
Lifecycle Management offers
a solution to post-approval
change challenges in the
form of a post-approval
change management protocol
(PACMP) (1).